Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model
The research and development of a pertussis-combined vaccine using a novel inactivated poliovirus vaccine made from the Sabin strain (sIPV) is of great significance in the polio eradication project and to address the recent resurge in pertussis. In the present study, we compared the immunogenicity a...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/1/47 |
_version_ | 1797489879158882304 |
---|---|
author | Xiaoyu Wang Na Gao Jiana Wen Jingyan Li Yan Ma Mingbo Sun Jiangli Liang Li Shi |
author_facet | Xiaoyu Wang Na Gao Jiana Wen Jingyan Li Yan Ma Mingbo Sun Jiangli Liang Li Shi |
author_sort | Xiaoyu Wang |
collection | DOAJ |
description | The research and development of a pertussis-combined vaccine using a novel inactivated poliovirus vaccine made from the Sabin strain (sIPV) is of great significance in the polio eradication project and to address the recent resurge in pertussis. In the present study, we compared the immunogenicity and efficacy of a candidate DTacP-sIPV with those of a commercial DTacP-wIPV/Hib, DTaP/Hib, pertussis vaccine, and aluminum hydroxide adjuvant control in the rhesus macaque model with a 0-, 1-, and 2-month immunization schedule. At day 28 after the third dose, rhesus macaques were challenged with aerosol pertussis and the antibody and cellular response together with pertussis clinical symptoms were determined. The production of anti-PT, anti-PRN, anti-FHA, anti-DT, anti-TT, and polio type I, II, III antibodies was induced by the candidate DTacP-sIPV, which was as potent as commercial vaccines. In comparison with the control group that showed typical pertussis symptoms of humans after the aerosol challenge, the DTacP-sIPV group did not exhibit obvious clinical pertussis symptoms and had higher neutralization titers of anti-PT, anti-PRN, and anti-FHA. In conclusion, the DTacP-sIPV vaccine was able to induce immunity in rhesus macaques to prevent pertussis infections after immunization. The developed vaccine was as efficient as other commercial vaccines. |
first_indexed | 2024-03-10T00:23:54Z |
format | Article |
id | doaj.art-8a382a0b068841ce805b87f384b4fbdd |
institution | Directory Open Access Journal |
issn | 2076-393X |
language | English |
last_indexed | 2024-03-10T00:23:54Z |
publishDate | 2021-12-01 |
publisher | MDPI AG |
record_format | Article |
series | Vaccines |
spelling | doaj.art-8a382a0b068841ce805b87f384b4fbdd2023-11-23T15:38:28ZengMDPI AGVaccines2076-393X2021-12-011014710.3390/vaccines10010047Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque ModelXiaoyu Wang0Na Gao1Jiana Wen2Jingyan Li3Yan Ma4Mingbo Sun5Jiangli Liang6Li Shi7Laboratory of Vaccine Development, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaKey Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaLaboratory of Vaccine Development, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaKey Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaLaboratory of Vaccine Development, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaLaboratory of Vaccine Development, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaKey Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaLaboratory of Immunogenetics, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaThe research and development of a pertussis-combined vaccine using a novel inactivated poliovirus vaccine made from the Sabin strain (sIPV) is of great significance in the polio eradication project and to address the recent resurge in pertussis. In the present study, we compared the immunogenicity and efficacy of a candidate DTacP-sIPV with those of a commercial DTacP-wIPV/Hib, DTaP/Hib, pertussis vaccine, and aluminum hydroxide adjuvant control in the rhesus macaque model with a 0-, 1-, and 2-month immunization schedule. At day 28 after the third dose, rhesus macaques were challenged with aerosol pertussis and the antibody and cellular response together with pertussis clinical symptoms were determined. The production of anti-PT, anti-PRN, anti-FHA, anti-DT, anti-TT, and polio type I, II, III antibodies was induced by the candidate DTacP-sIPV, which was as potent as commercial vaccines. In comparison with the control group that showed typical pertussis symptoms of humans after the aerosol challenge, the DTacP-sIPV group did not exhibit obvious clinical pertussis symptoms and had higher neutralization titers of anti-PT, anti-PRN, and anti-FHA. In conclusion, the DTacP-sIPV vaccine was able to induce immunity in rhesus macaques to prevent pertussis infections after immunization. The developed vaccine was as efficient as other commercial vaccines.https://www.mdpi.com/2076-393X/10/1/47DTacP-sIPV candidate vaccineimmunogenicityefficacyrhesus macaque model |
spellingShingle | Xiaoyu Wang Na Gao Jiana Wen Jingyan Li Yan Ma Mingbo Sun Jiangli Liang Li Shi Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model Vaccines DTacP-sIPV candidate vaccine immunogenicity efficacy rhesus macaque model |
title | Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model |
title_full | Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model |
title_fullStr | Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model |
title_full_unstemmed | Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model |
title_short | Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model |
title_sort | immunogenicity of a candidate dtacp sipv combined vaccine and its protection efficacy against pertussis in a rhesus macaque model |
topic | DTacP-sIPV candidate vaccine immunogenicity efficacy rhesus macaque model |
url | https://www.mdpi.com/2076-393X/10/1/47 |
work_keys_str_mv | AT xiaoyuwang immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel AT nagao immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel AT jianawen immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel AT jingyanli immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel AT yanma immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel AT mingbosun immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel AT jiangliliang immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel AT lishi immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel |